Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Classical hematology 3Myeloid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Leukemia 21Lymphoma 7Burkitt Lymphoma 6Leukemia, Myeloid, Acute 5Leukemia, Biphenotypic, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Anemia, Refractory, with Excess of Blasts 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Down Syndrome 2Anemia, Refractory 2Sarcoma, Myeloid 1Recurrence 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Basophilic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Cardiotoxicity 1

Interventions

Cytarabine 9Daunorubicin 7Etoposide 6Methotrexate 5Idarubicin 5Thioguanine 4Mitoxantrone 4Cyclophosphamide 4Hydrocortisone 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Asparaginase 3Tacrolimus 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2ON 01910 2Mycophenolic Acid 2Dexamethasone 2Busulfan 2zosuquidar trihydrochloride 1valspodar 1tipifarnib 1sargramostim 1palmitoyl-L-asparaginase 1merphos 1lonafarnib 1hydrocortisone hemisuccinate 1fludarabine phosphate 1fludarabine 1cc-486 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Anemia, Refractory, with Excess of Blasts × Asparaginase × Clear all
NCT00003436 2013-12-04

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Completed
2,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

NCT00003593 2013-06-27

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

Children's Oncology Group

Phase 3 Completed
254 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

NCT00002798 2013-01-16

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Completed
880 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡